| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for an inactivated viral vaccine against Chikungunya virus
|
Hernandez, Libia Milena
|
|
|
40 |
35 |
p. 5263-5274
|
artikel
|
| 2 |
A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for the Moderna COVID-19 Vaccine (mRNA-1273)
|
Leav, Brett
|
|
|
40 |
35 |
p. 5275-5293
|
artikel
|
| 3 |
Burden of pertussis among young infants in Malaysia: A hospital-based surveillance study
|
Mohamed, Thahira J.
|
|
|
40 |
35 |
p. 5241-5247
|
artikel
|
| 4 |
Comparative effectiveness of individual pneumococcal vaccines with dual pneumococcal vaccination in older United States Veterans
|
Narsingam, Saiprasad
|
|
|
40 |
35 |
p. 5223-5228
|
artikel
|
| 5 |
COVID-19 vaccination intention and activation among health care system employees: A mixed methods study
|
Vasudevan, Lavanya
|
|
|
40 |
35 |
p. 5141-5152
|
artikel
|
| 6 |
COVID-19 vaccinations in German pharmacies: A survey on patient and provider satisfaction
|
Rose, Olaf
|
|
|
40 |
35 |
p. 5207-5212
|
artikel
|
| 7 |
COVID-19 vaccine express strategy in Malawi: An effort to reach the un-reach
|
Sethy, Ghanashyam
|
|
|
40 |
35 |
p. 5089-5094
|
artikel
|
| 8 |
CpG 1018® adjuvant enhances Tdap immune responses against Bordetella pertussis in mice
|
DeJong, Megan A.
|
|
|
40 |
35 |
p. 5229-5240
|
artikel
|
| 9 |
Deciding about maternal pertussis vaccination: associations between intention, and needs and values in a vaccine-hesitant religious group
|
de Munter, Anne C.
|
|
|
40 |
35 |
p. 5213-5222
|
artikel
|
| 10 |
Editorial Board/Aims and Scope
|
|
|
|
40 |
35 |
p. IFC
|
artikel
|
| 11 |
EEHV1A glycoprotein B subunit vaccine elicits humoral and cell-mediated immune responses in mice
|
Spencer Clinton, Jennifer L.
|
|
|
40 |
35 |
p. 5131-5140
|
artikel
|
| 12 |
Genetically detoxified tetanus toxin as a vaccine and conjugate carrier protein
|
Chang, Min-Ju
|
|
|
40 |
35 |
p. 5103-5113
|
artikel
|
| 13 |
Humoral immune response characterization of heterologous prime-boost vaccination with CoronaVac and BNT162b2
|
Rammauro, Florencia
|
|
|
40 |
35 |
p. 5189-5196
|
artikel
|
| 14 |
Long-term control of Coxiellosis in sheep by annual primary vaccination of gimmers
|
Böttcher, Jens
|
|
|
40 |
35 |
p. 5197-5206
|
artikel
|
| 15 |
Modestly protective cytomegalovirus vaccination of young children effectively prevents congenital infection at the population level
|
Byrne, Catherine
|
|
|
40 |
35 |
p. 5179-5188
|
artikel
|
| 16 |
Protective immunity of plant-produced African horse sickness virus serotype 5 chimaeric virus-like particles (VLPs) and viral protein 2 (VP2) vaccines in IFNAR-/- mice
|
O'Kennedy, Martha M.
|
|
|
40 |
35 |
p. 5160-5169
|
artikel
|
| 17 |
Risk of myocarditis and pericarditis following BNT162b2 and mRNA-1273 COVID-19 vaccination
|
Goddard, Kristin
|
|
|
40 |
35 |
p. 5153-5159
|
artikel
|
| 18 |
Rotavirus vaccine-derived cases in Belgium: Evidence for reversion of attenuating mutations and alternative causes of gastroenteritis
|
Simsek, Ceren
|
|
|
40 |
35 |
p. 5114-5125
|
artikel
|
| 19 |
Serum-free purified Vero rabies vaccine is safe and immunogenic in children: Results of a randomized phaseII pre-exposure prophylaxis regimen study
|
Quiambao, Beatriz
|
|
|
40 |
35 |
p. 5170-5178
|
artikel
|
| 20 |
The Addis Declaration on Immunization: A binding reminder of the political support needed to achieve universal immunization in Africa
|
Mihigo, Richard M.
|
|
|
40 |
35 |
p. 5126-5130
|
artikel
|
| 21 |
The impact of universal varicella vaccination on the clinical burden of varicella in Colombia: A National database Analysis, 2008–2019
|
Pawaskar, Manjiri
|
|
|
40 |
35 |
p. 5095-5102
|
artikel
|
| 22 |
Vaccines based on the replication-deficient simian adenoviral vector ChAdOx1: Standardized template with key considerations for a risk/benefit assessment
|
Folegatti, Pedro M
|
|
|
40 |
35 |
p. 5248-5262
|
artikel
|
Tijdschrift beschrijving